Empagliflozin-Induced Acute Pancreatitis and Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes Mellitus. (2022). American Journal of Chemistry and Pharmacy, 1(2), 1-4. https://doi.org/10.54536/ajcp.v1i2.747